{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:51:47Z","timestamp":1791341507828,"version":"4.3.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.01179","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:03:45Z","timestamp":1573085025000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With Nusinersen"],"prefix":"10.3389","volume":"10","author":[{"given":"Claudia D.","family":"Wurster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan C.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabell","family":"Cordts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Dreyhaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeljko","family":"Uzelac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Witzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugrul","family":"Kocak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schocke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Weydt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Wollinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert C.","family":"Ludolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Deschauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lingor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayrettin","family":"Tumani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/S0140-6736(08)60921-6","article-title":"Spinal muscular atrophy","volume":"371","author":"Lunn","year":"2008","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrneurol.2018.4","article-title":"Advances in therapy for spinal muscular atrophy: promises and challenges","volume":"14","author":"Groen","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1756286418776932","DOI":"10.1177\/1756286418776932","article-title":"Antisense oligonucleotides in neurological disorders","volume":"11","author":"Wurster","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"B4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1146\/annurev-pharmtox-010716-104846","article-title":"Pharmacology of antisense drugs","volume":"57","author":"Bennett","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s40278-018-50183-2","volume":"1714","year":"2018","journal-title":"React Wkly"},{"key":"B6","volume-title":"Product Information","year":"2019"},{"key":"B7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-510X(94)90298-4","article-title":"Flow rate of cerebrospinal fluid (CSF)\u2013a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases","volume":"122","author":"Reiber","year":"1994","journal-title":"J Neurol Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1756286419846058","DOI":"10.1177\/1756286419846058","article-title":"Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment","volume":"12","author":"Wurster","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"key":"B9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/9781444328394.ch1","article-title":"Routine cerebrospinal fluid (CSF) analysis","volume":"1","author":"Deisenhammer","year":"2010","journal-title":"Eur Handb Neurol Manag Second Ed"},{"key":"B10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.nmd.2009.11.014","article-title":"The children's hospital of philadelphia infant test of neuromuscular disorders (CHOP INTEND): test development and reliability The CHOP INTEND is a reliable measure of motor skills in patients with SMA-I and neuromuscular disorders presenting in infancy","volume":"20","author":"Glanzman","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1177\/0883073811420294","article-title":"Validation of the expanded hammersmith functional motor scale in spinal muscular atrophy type II and III","volume":"26","author":"Glanzman","year":"2011","journal-title":"J Child Neurol"},{"key":"B12","first-page":"2081","article-title":"Physikalisch-chemische, zytologische und anderweitig Untersuchungen der Cerebrospinalfl\u00fcssigkeit","volume":"45","author":"Fuchs","year":"1904","journal-title":"Wien Med Press"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1007\/s00415-010-5876-x","article-title":"Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases","volume":"258","author":"Jesse","year":"2011","journal-title":"J Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s00415-005-0817-9","article-title":"Isolated blood-cerebrospinal fluid barrier dysfunction: prevalence and associated diseases","volume":"252","author":"Brettschneider","year":"2005","journal-title":"J Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1177\/000456329002700504","article-title":"Isoelectric focusing of cerebrospinal fluid immunoglobulin G: an annotated update","volume":"27","author":"Keir","year":"1990","journal-title":"Ann Clin Biochem"},{"key":"B16","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","article-title":"Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report","volume":"57","author":"Andersson","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/fcp.12349","article-title":"Drug-induced aseptic meningitis: a mini-review","volume":"32","author":"Yelehe-Okouma","year":"2018","journal-title":"Fundam Clin Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12975-012-0182-9","article-title":"Mechanisms of hydrocephalus after neonatal and adult intraventricular hemorrhage","volume":"3","author":"Strahle","year":"2012","journal-title":"Transl Stroke Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"8584753","DOI":"10.1155\/2017\/8584753","article-title":"Hydrocephalus after subarachnoid hemorrhage: pathophysiology, diagnosis, and treatment","volume":"2017","author":"Chen","year":"2017","journal-title":"Biomed Res Int"},{"key":"B20","volume-title":"The CSF Proteins: A Biochemical Approach","author":"Thompson","year":"2005"},{"key":"B21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/B978-0-12-804279-3.00002-2","article-title":"The cerebrospinal fluid and barriers - anatomic and physiologic considerations","volume":"146","author":"Tumani","year":"2017","journal-title":"Handb Clin Neurol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0022-510X(76)90259-8","article-title":"Evaluation of the blood-CSF barrier by protein gradients and the humoral immune response within the central nervous system","volume":"30","author":"Felgenhauer","year":"1976","journal-title":"J Neurol Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1469-8749.1983.tb13738.x","article-title":"Development of the blood-CSF barrier","volume":"25","author":"Statz","year":"1983","journal-title":"Dev Med Child Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/0022-510X(91)90218-V","article-title":"Age-related changes in cerebrospinal fluid protein concentrations","volume":"104","author":"Garton","year":"1991","journal-title":"J Neurol Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/BF01962340","article-title":"Value of cerebrospinal fluid analysis in the differential diagnosis of meningitis: a study in 710 patients with suspected central nervous system infection","volume":"7","author":"Lindquist","year":"1988","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/archneur.1983.04050020043008","article-title":"Comparison of cryptococcal and tuberculous meningitis","volume":"40","author":"Stockstill","year":"1983","journal-title":"Arch Neurol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s004150050214","article-title":"Neuroborreliosis","volume":"245","author":"Kaiser","year":"1998","journal-title":"J Neurol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/clinids\/6.5.608","article-title":"Cerebrospinal fluid alterations in herpes simplex virus encephalitis","volume":"6","author":"Koskiniemi","year":"1984","journal-title":"Rev Infect Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/BF00314019","article-title":"Clinical significance of serum and CSF findings in the Guillain-Barre syndrome and related disorders","volume":"233","author":"Segurado","year":"1986","journal-title":"J Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/cncr.24041","article-title":"Leptomeningeal carcinomatosis: prognostic implications of clinical and cerebrospinal fluid features","volume":"115","author":"Bruna","year":"2009","journal-title":"Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.2174\/092986708785133031","article-title":"Biochemical markers in CSF of ALS patients","volume":"15","author":"Sussmuth","year":"2008","journal-title":"Curr Med Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/0304-3940(87)90700-2","article-title":"Alcohol consumption and blood-cerebrospinal fluid barrier dysfunction in man","volume":"79","author":"Kornhuber","year":"1987","journal-title":"Neurosci Lett."},{"key":"B33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/00002517-199407010-00002","article-title":"Cerebrospinal fluid protein concentrations related to clinical findings in patients with sciatica caused by disk herniation","volume":"7","author":"Skouen","year":"1994","journal-title":"J Spinal Disord"},{"key":"B34","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1600-0404.1997.tb00216.x","article-title":"Cerebrospinal fluid proteins in subclinical and overt hypothyroidism","volume":"95","author":"Nystrom","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00415-002-0777-2","article-title":"Determinants of lumbar CSF protein concentration","volume":"249","author":"Seyfert","year":"2002","journal-title":"J Neurol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jns.2017.08.3264","article-title":"Cerebrospinal fluid total protein in idiopathic intracranial hypertension","volume":"381","author":"Berezovsky","year":"2017","journal-title":"J Neurol Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12987-019-0129-6","article-title":"Cerebrospinal fluid dynamics and intracranial pressure elevation in neurological diseases","volume":"16","author":"Bothwell","year":"2019","journal-title":"Fluids Barriers CNS"},{"key":"B38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00415-016-8360-4","article-title":"The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature","volume":"264","author":"Jarius","year":"2017","journal-title":"J Neurol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.neuron.2017.04.010","article-title":"Antisense oligonucleotides: translation from mouse models to human neurodegenerative diseases","volume":"94","author":"Schoch","year":"2017","journal-title":"Neuron"},{"key":"B40","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","article-title":"Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy","volume":"86","author":"Chiriboga","year":"2016","journal-title":"Neurology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1474-4422(13)70061-9","article-title":"An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study","volume":"12","author":"Miller","year":"2013","journal-title":"Lancet Neurol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting Huntingtin expression in patients with Huntington's disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01179\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:03:47Z","timestamp":1573085027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.01179\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,7]]},"references-count":42,"alternative-id":["10.3389\/fneur.2019.01179"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.01179","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,7]]},"article-number":"1179"}}